For a 10mg vial providing 5 doses at 2mg each, dead space losses of approximately 1 unit per draw mean roughly 5 units (50mcg at 10mg/mL) lost total
Trial results indicate that the GLP-1 RAs appear to slow the progression of atherosclerosis (plaque) in the arteries and stabilize it, making it less likely to clog the arteries and less likely to become unstable to cause heart attacks and strokes
Reduces the appearance of dark circles beneath the eyes
The broad range of biological pathways affected by these agents holds the promise of therapeutic benefit across multiple disease states (as has been seen already for SGLT2 inhibitors [182, 183]) but also necessitates careful assessment of potential harms across multiple organ systems
While both compounds demonstrate remarkable individual efficacy and work through complementary mechanisms that theoretically could synergize, the complete absence of clinical trial data makes any combination approach purely experimental
These programs can offer reduced pricesor even free medicationfor qualifying individuals based on income or medical need